Related references
Note: Only part of the references are listed.Inflammation in multiple sclerosis: consequences for remyelination and disease progression
Luisa Klotz et al.
NATURE REVIEWS NEUROLOGY (2023)
IL-33 and HMGB1 modulate the progression of EAE via oppositely regulating each other
Mengya Jiao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
Juvenile multiple sclerosis: addressing epidemiology, diagnosis, therapeutic, and prognostic updates along with cognitive dysfunction and quality of life
Priyadarshi Prajjwal et al.
Annals of Medicine and Surgery (2023)
Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination
Martin Zirngibl et al.
MOLECULAR NEURODEGENERATION (2022)
Dual roles of interleukin-33 in cognitive function by regulating central nervous system inflammation
Xiuqin Rao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Interleukin-33 regulates the endoplasmic reticulum stress of human myometrium via an influx of calcium during initiation of labor
Li Chen et al.
ELIFE (2022)
Life-long oligodendrocyte development and plasticity
Akiko Nishiyama et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
Glial IL-33 signaling through an ST2-to-CXCL12 pathway in the spinal cord contributes to morphine-induced hyperalgesia and tolerance
Xue-Ming Hu et al.
SCIENCE SIGNALING (2021)
Oligodendrocyte lineage cells and depression
Butian Zhou et al.
MOLECULAR PSYCHIATRY (2021)
Behavioural and histological changes in cuprizone-fed mice
Monokesh K. Sen et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment
Marina Saresella et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration
John Shelestak et al.
PLOS ONE (2020)
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
Astrid De Boeck et al.
NATURE COMMUNICATIONS (2020)
The role of myelin damage in Alzheimer's disease pathology
Ewa Papuc et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-B
Duraisamy Kempuraj et al.
MOLECULAR NEUROBIOLOGY (2019)
BRCA1/BRCA2-containing complex subunit 3 controls oligodendrocyte differentiation by dynamically regulating lysine 63-linked ubiquitination
Chih-Yen Wang et al.
GLIA (2019)
Down-regulation of interleukin-33 expression in oligodendrocyte precursor cells impairs oligodendrocyte lineage progression
Hsin-Yu Sung et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Interleukin-33 reduces neuronal damage and white matter injury via selective microglia M2 polarization after intracerebral hemorrhage in rats
Zhouqing Chen et al.
BRAIN RESEARCH BULLETIN (2019)
Behavioural phenotypes in the cuprizone model of central nervous system demyelination
Monokesh K. Sen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
Ben C. L. Chan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
Corinne Cayrol et al.
IMMUNOLOGICAL REVIEWS (2018)
Interleukin-33 Protects Ischemic Brain Injury by Regulating Specific Microglial Activities
Qianping Luo et al.
NEUROSCIENCE (2018)
Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development
Ilia D. Vainchtein et al.
SCIENCE (2018)
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
Loris R. Lopetuso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
IL-33 Exerts Neuroprotective Effect in Mice Intracerebral Hemorrhage Model Through Suppressing Inflammation/Apoptotic/Autophagic Pathway
Yuan Gao et al.
MOLECULAR NEUROBIOLOGY (2017)
ST2/IL-33-Dependent Microglial Response Limits Acute Ischemic Brain Injury
Yuanyuan Yang et al.
JOURNAL OF NEUROSCIENCE (2017)
IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria
Flora Reverchon et al.
PLOS PATHOGENS (2017)
Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
Stefan A. Berghoff et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Behavioral Changes in Mice Lacking Interleukin-33
Eisuke Dohi et al.
ENEURO (2017)
The cell biology of CNS myelination
Ethan G. Hughes et al.
CURRENT OPINION IN NEUROBIOLOGY (2016)
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair
Chandramohan Natarajan et al.
PLOS ONE (2016)
Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system
Debbie Allan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation
Paula Korhonen et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice
Sabine Pfeifenbring et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury
Sachin P. Gadani et al.
NEURON (2015)
Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells
Kuan-Min Fang et al.
NEURO-ONCOLOGY (2014)
The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis
Annelies Nonneman et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2014)
Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model
P. Acs et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes
Karelle Benardais et al.
NEUROTOXICITY RESEARCH (2013)
Demyelination in Mild Cognitive Impairment Suggests Progression Path to Alzheimer's Disease
Cristian Carmeli et al.
PLOS ONE (2013)
Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit
Hongkai Wang et al.
NEUROSCIENCE BULLETIN (2013)
IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages
Hui-Rong Jiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Amyotrophic Lateral Sclerosis with Demyelinating Neuropathy
Haruo Nishijima et al.
INTERNAL MEDICINE (2012)
The cuprizone animal model: new insights into an old story
Markus Kipp et al.
ACTA NEUROPATHOLOGICA (2009)
Induction of IL-33 expression and activity in central nervous system glia
Chad A. Hudson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia
L. A. Pasquini et al.
NEUROCHEMICAL RESEARCH (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)